4311-2225 Screening compound: 3-ethyl-6-methyl-2-{[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2-ylidene]methyl}-1,3-benzothiazol-3-ium

4311-2225 Screening compound: 3-ethyl-6-methyl-2-{[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2-ylidene]methyl}-1,3-benzothiazol-3-ium
4311-2225 Screening compound: 3-ethyl-6-methyl-2-{[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2-ylidene]methyl}-1,3-benzothiazol-3-ium alternative view

Chemical Structure Depiction of ChemDiv screening compound 4311-2225
3-ethyl-6-methyl-2-{[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2-ylidene]methyl}-1,3-benzothiazol-3-ium

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4311-2225

Molecular Formula

C21H22N2O3S3 (C21 H22 N2 O3 S3)

Compound Name

3-ethyl-6-methyl-2-{[(2Z)-3-(3-sulfonatopropyl)-2,3-dihydro-1,3-benzothiazol-2-ylidene]methyl}-1,3-benzothiazol-3-ium

IUPAC name

3-ethyl-6-methyl-2-{[(2Z)-3-(3-sulfonatopropyl)-23-dihydro-13-benzothiazol-2-ylidene]methyl}-13-benzothiazol-3-ium

SMILES

CC[n+]1c(/C=C2\Sc(cccc3)c3N2CCCS([O-])(=O)=O)sc2c1ccc(C)c2

InChI

InChI=1S/C21H22N2O3S3/c1-3-22-17-10-9-15(2)13-19(17)28-20(22)14-21-23(11-6-12-29(24,25)26)16-7-4-5-8-18(16)27-21/h4-5,7-10,13-14H,3,6,11-12H2,1-2H3

InChI Key

IEAXETDXSLLNOH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03161702

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.62

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.820

Distribution Coefficient, logD

3.820

Water Solubility, LogSw

-3.85

Polar Surface Area

45.455

Acid Dissociation Constant (pKa)

21.65

Base Dissociation Constant (pKb)

-1.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

4311-2225 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 4311-2225 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4311-2225?
Check Price and Availability of 4311-2225, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4311-2225 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4311-2225
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4311-2225
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4311-2225 available by request